Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study

Background: Association between baseline medications plus neutrophil-to-lymphocyte ratio (NLR) and the effectiveness of immune checkpoint inhibitor (ICI) plus platinum doublet remains unknown, despite several reported prognostic models. We used real-world data to investigate whether baseline medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasu, Izumi, Kondo, Masahiro, Uozumi, Ryuji, Takada, Shinya, Nawata, Shuichi, Iihara, Hirotoshi, Okumura, Yohei, Takemoto, Masashi, Mino, Kozo, Sasaki, Tadanori, Hirose, Chiemi, Aomori, Tohru, Shimano, Rena, Maeno, Ken, Oizumi, Satoshi, Kusumoto, Sojiro, Ohno, Yasushi, Ikemura, Shinnosuke, Takai, Daiya, Hara, Azusa, Kawazoe, Hitoshi, Nakamura, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088894/
https://www.ncbi.nlm.nih.gov/pubmed/37056385
http://dx.doi.org/10.7150/jca.80517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088894/
https://www.ncbi.nlm.nih.gov/pubmed/37056385
http://dx.doi.org/10.7150/jca.80517

Ejemplares similares